<p>Novo Integrated Sciences Inc. announced changes in its management team. Robert Mattacchione will resign as Chief Executive Officer by May 31, 2025, to facilitate a smooth transition. He will continue his roles as Chairman of the Board of Directors and Chairman of Novo Healthnet Limited. Additionally, Michael Pope has resigned from the Board effective May 1, 2025. Both departures are not due to any disagreements with the company. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novo Integrated Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-008853), on May 06, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

NVOS

<p>Novo Integrated Sciences Inc. announced that CEO Robert Mattacchione will resign by May 31, 2025, while remaining as Chairman of the Board. Board member Michael Pope will also resign effective May 1, 2025. Both departures are amicable and not due to disagreements with the company.</p>

- Novo Integrated Sciences Inc. announced management changes, with Robert Mattacchione resigning as CEO by May 31, 2025, while remaining Chairman of the Board.  
- Michael Pope also resigned from the Board effective May 1, 2025, with both departures not resulting from disagreements with the company.  
- The information was generated by Public Technologies and is based on content published by Novo Integrated Sciences Inc. via EDGAR.

Novo Integrated Sciences Announces CEO Robert Mattacchione's Extended Resignation Date and Board Member Michael Pope's Departure